{"title":"ExoU-Mediated Host-Cell Cytotoxicity is Associated with Phosphorylation-Dependent Regulation of DDX3Y during Pseudomonas aeruginosa Infection","authors":"Cheng Nong, Derong Dai, Yibo Zhu, Yunjiao Li, Jiajin Chenghuang, Mingming Gao, Jianping Ying, Yuxiao Gui, Rui Bao","doi":"10.1021/acsinfecdis.6c00279","DOIUrl":null,"url":null,"abstract":"<p>The <em>Pseudomonas aeruginosa</em> type\r\nIII secretion system effector ExoU is a potent phospholipase A2 that\r\ncauses rapid host-cell injury, but how it engages intracellular host\r\nnetworks during infection remains incompletely understood. Here, using\r\nan endogenously Flag-tagged infection model in male-derived A549 cells,\r\nwe identified MYH6 and DDX3Y as ExoU-associated host factors. Knockdown\r\nof either protein reduced PA14-induced cytotoxicity, indicating that\r\nboth contribute to the cellular response to ExoU-positive <em>P. aeruginosa</em>. An in vitro pull-down assay using\r\npurified proteins further supported a direct but relatively weak association\r\nbetween ExoU-S142A and DDX3Y. Quantitative phosphoproteomic analysis\r\nrevealed extensive host phosphorylation changes associated with ExoU\r\ncatalytic activity and identified multiple phosphorylation sites on\r\nDDX3Y. Phosphorylation at S506 was detected following PA14 infection\r\nbut not following <em>exoU</em>-S142A infection. Phospho-deficient\r\nDDX3Y mutants at S101, S141, and S506 showed increased association\r\nwith ExoU, whereas the combined S101A/S141A/S506A mutant further enhanced\r\nthis association and reduced infection-induced cytotoxicity. Conversely,\r\nthe phosphomimetic S506E mutant showed reduced association with ExoU\r\nand restored cytotoxicity relative to S506A. RNA sequencing and DDX3Y\r\nRIP analyses further showed that ExoU catalytic activity was associated\r\nwith a broader inflammatory transcriptional response and with changes\r\nin the DDX3Y-bound transcriptome, including altered association with <em>IL6ST</em> and <em>NFKBIZ</em> transcripts. Together,\r\nthese findings identify MYH6 and DDX3Y as distinct ExoU-associated\r\nhost factors and support a model in which ExoU catalytic activity\r\nis linked to multisite regulation of DDX3Y, altered ExoU-DDX3Y association,\r\nand changes in DDX3Y-associated RNAs. These results extend the current\r\nunderstanding of ExoU-mediated cytotoxicity beyond direct membrane\r\ndamage.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":"12 10","pages":"3335–3350"},"PeriodicalIF":4.5000,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsinfecdis.6c00279","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/25 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
The Pseudomonas aeruginosa type
III secretion system effector ExoU is a potent phospholipase A2 that
causes rapid host-cell injury, but how it engages intracellular host
networks during infection remains incompletely understood. Here, using
an endogenously Flag-tagged infection model in male-derived A549 cells,
we identified MYH6 and DDX3Y as ExoU-associated host factors. Knockdown
of either protein reduced PA14-induced cytotoxicity, indicating that
both contribute to the cellular response to ExoU-positive P. aeruginosa. An in vitro pull-down assay using
purified proteins further supported a direct but relatively weak association
between ExoU-S142A and DDX3Y. Quantitative phosphoproteomic analysis
revealed extensive host phosphorylation changes associated with ExoU
catalytic activity and identified multiple phosphorylation sites on
DDX3Y. Phosphorylation at S506 was detected following PA14 infection
but not following exoU-S142A infection. Phospho-deficient
DDX3Y mutants at S101, S141, and S506 showed increased association
with ExoU, whereas the combined S101A/S141A/S506A mutant further enhanced
this association and reduced infection-induced cytotoxicity. Conversely,
the phosphomimetic S506E mutant showed reduced association with ExoU
and restored cytotoxicity relative to S506A. RNA sequencing and DDX3Y
RIP analyses further showed that ExoU catalytic activity was associated
with a broader inflammatory transcriptional response and with changes
in the DDX3Y-bound transcriptome, including altered association with IL6ST and NFKBIZ transcripts. Together,
these findings identify MYH6 and DDX3Y as distinct ExoU-associated
host factors and support a model in which ExoU catalytic activity
is linked to multisite regulation of DDX3Y, altered ExoU-DDX3Y association,
and changes in DDX3Y-associated RNAs. These results extend the current
understanding of ExoU-mediated cytotoxicity beyond direct membrane
damage.
期刊介绍:
ACS Infectious Diseases will be the first journal to highlight chemistry and its role in this multidisciplinary and collaborative research area. The journal will cover a diverse array of topics including, but not limited to:
* Discovery and development of new antimicrobial agents — identified through target- or phenotypic-based approaches as well as compounds that induce synergy with antimicrobials.
* Characterization and validation of drug target or pathways — use of single target and genome-wide knockdown and knockouts, biochemical studies, structural biology, new technologies to facilitate characterization and prioritization of potential drug targets.
* Mechanism of drug resistance — fundamental research that advances our understanding of resistance; strategies to prevent resistance.
* Mechanisms of action — use of genetic, metabolomic, and activity- and affinity-based protein profiling to elucidate the mechanism of action of clinical and experimental antimicrobial agents.
* Host-pathogen interactions — tools for studying host-pathogen interactions, cellular biochemistry of hosts and pathogens, and molecular interactions of pathogens with host microbiota.
* Small molecule vaccine adjuvants for infectious disease.
* Viral and bacterial biochemistry and molecular biology.